Cargando…

Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole

PURPOSE: Proton pump inhibitors (PPIs) are the first-line therapy for gastroesophageal reflux disorder (GERD). Unlike conventional PPIs, non-enteric coated PPIs with antacid salt enable a faster acid suppression through the rapid absorption of the PPI. YPI-011 is a newly developed fixed-dose combina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Sungyeun, Kwon, Jihoon, Lee, Mi-Hye, Yu, Kyung-Sang, Lee, SeungHwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939800/ https://www.ncbi.nlm.nih.gov/pubmed/36814893 http://dx.doi.org/10.2147/DDDT.S391716

Ejemplares similares

Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011)

Gastrointestinal bleed induced by a fixed dose combination of rabeprazole and diclofenac sodium
por: Tandon, Vishal R., et al.
Publicado: (2014)

Multiple widespread fixed drug eruption caused by rabeprazole
por: Gupta, S, et al.
Publicado: (2020)

Stability-indicating HPLC–DAD methods for determination of two binary mixtures: Rabeprazole sodium–mosapride citrate and rabeprazole sodium–itopride hydrochloride
por: El-Fatatry, Hamed M., et al.
Publicado: (2014)

Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
por: Lee, Sang-Ho, et al.
Publicado: (2021)

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

Quantitative Estimation of Itopride Hydrochloride and Rabeprazole Sodium from Capsule Formulation
por: Pillai, S., et al.
Publicado: (2008)

In Vitro Effects of Rabeprazole on Human Pylorus Tone
por: Yaşar, Necdet Fatih, et al.
Publicado: (2015)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

A review of rabeprazole in the treatment of acid-related diseases
por: Pace, Fabio, et al.
Publicado: (2007)

Effect of rabeprazole on the transport and distribution of levofloxacin in rat stomachs
por: BAO, JUNJUN, et al.
Publicado: (2014)

Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers
por: Chan, Noel, et al.
Publicado: (2022)

Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules
por: Tan, Yinhe, et al.
Publicado: (2016)

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants
por: Xu, Huiping, et al.
Publicado: (2021)

Spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac from the combined capsule dosage form
por: Sawant, Ramesh L., et al.
Publicado: (2011)

Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
por: Bae, Sungyeun, et al.
Publicado: (2021)

Ten mg dexrabeprazole daily is as effective as 20 mg rabeprazole daily
por: Kanakia, Rajendra, et al.
Publicado: (2008)

Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines
por: GU, MENGLI, et al.
Publicado: (2014)

Exploring Differences in Pharmacometrics of Rabeprazole between Genders via Population Pharmacokinetic–Pharmacodynamic Modeling
por: Jeong, Seung-Hyun, et al.
Publicado: (2023)

Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form
por: Suganthi, A., et al.
Publicado: (2008)

Rabeprazole inhibits inflammatory reaction by inhibition of cell pyroptosis in gastric epithelial cells
por: Xie, Jing, et al.
Publicado: (2021)

Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase
por: García-Torres, Itzhel, et al.
Publicado: (2023)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013)

Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique
por: Khan, Ruqaiyah, et al.
Publicado: (2014)

Validation and Application of a New Reversed Phase HPLC Method for In Vitro Dissolution Studies of Rabeprazole Sodium in Delayed-Release Tablets
por: Nawaz, Md. Saddam
Publicado: (2013)

Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux
por: Shin, Myung-Hee, et al.
Publicado: (2012)

A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form
por: Raval, P. B., et al.
Publicado: (2008)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
por: Lin, Tsung-Jung, et al.
Publicado: (2018)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
por: Kim, Hyung-Keun, et al.
Publicado: (2012)

Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules
por: Thummala, Veera Raghava Raju, et al.
Publicado: (2014)

A multicenter randomized trial comparing rabeprazole and itopride in patients with functional dyspepsia in Japan: the NAGOYA study
por: Kamiya, Takeshi, et al.
Publicado: (2017)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
por: Wu, Meng-Chieh, et al.
Publicado: (2017)

Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation
por: Kumar, Navneet, et al.
Publicado: (2013)

Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis
por: Lin, Meisi, et al.
Publicado: (2020)

Rabeprazole Promotes Vascular Repair and Resolution of Sepsis-Induced Inflammatory Lung Injury through HIF-1α
por: Evans, Colin E., et al.
Publicado: (2022)

Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ac68na69vdifq1r17bqefau9vt